A new study by the University of Bristol has found that Covid-19 may contribute to the heart damage seen in severely-ill patients.
It found that the virus may transform human heart vascular cells into inflammatory cells, without infecting them.
The University of Bristol-led research, published in Clinical Science , said that indicated that blocking antibodies could therefore be a new treatment to alleviate cardiovascular complications of Covid.
